(Q45239341)

11 December 2017

title

Creatine supplementation lowers brain glutamate levels in Huntington's disease (English)

1 reference

11 December 2017

0 references

2

1 reference

11 December 2017

Ralf Reilmann

4

0 references

Thomas Gasser

10

object named as

Thomas Gasser

1 reference

11 December 2017

Andreas Bender

1

1 reference

11 December 2017

Thomas Merl

3

1 reference

11 December 2017

Phillip Saemann

5

1 reference

11 December 2017

Alexander Yassouridis

6

1 reference

11 December 2017

Julia Bender

7

1 reference

11 December 2017

Adolf Weindl

8

1 reference

11 December 2017

Matthias Dose

9

1 reference

11 December 2017

Thomas Klopstock

11

1 reference

11 December 2017

publication date

1 January 2005

1 reference

11 December 2017

1 reference

11 December 2017

volume

252

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

36-41

1 reference

1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0595-4

Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0595-4

Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0595-4

Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0595-4

The role of creatine kinase in inhibition of mitochondrial permeability transition

21 January 2018

1 reference

12 December 2020

Protective Effect of the Energy Precursor Creatine Against Toxicity of Glutamate and β-Amyloid in Rat Hippocampal Neurons

1 reference

12 December 2020

Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid

1 reference

12 December 2020

Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation.

1 reference

12 December 2020

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

12 December 2020

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

1 reference

12 December 2020

Compartmentation of brain glutamate metabolism in neurons and glia

1 reference

12 December 2020

Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.

1 reference

12 December 2020

Oral creatine supplementation and athletic performance: a critical review

1 reference

12 December 2020

On the mechanisms of neuroprotection by creatine and phosphocreatine

1 reference

12 December 2020

What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies

1 reference

12 December 2020

Direct antioxidant properties of creatine

1 reference

12 December 2020

Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy

1 reference

12 December 2020

Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation

1 reference

12 December 2020

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

1 reference

12 December 2020

Mitochondrial defect in Huntington's disease caudate nucleus

1 reference

12 December 2020

Creatine and cyclocreatine attenuate MPTP neurotoxicity

1 reference

12 December 2020

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

1 reference

12 December 2020

Metabolism and role of glutamate in mammalian brain

1 reference

12 December 2020

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

1 reference

12 December 2020

Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory

1 reference

12 December 2020

Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease

1 reference

12 December 2020

Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice

1 reference

12 December 2020

Effect of creatine supplementation on metabolite levels in ALS motor cortices

1 reference

12 December 2020

Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats

1 reference

12 December 2020

Glucose and synaptosomal glutamate metabolism: studies with [15N]glutamate

1 reference

12 December 2020

Creatine in humans with special reference to creatine supplementation

1 reference

12 December 2020

Phosphocreatine-dependent Glutamate Uptake by Synaptic Vesicles

1 reference

12 December 2020

Direct Evidence for the Control of Mitochondrial Respiration by Mitochondrial Creatine Kinase in Oxidative Muscle Cellsin Situ

1 reference

12 December 2020

In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics

1 reference

12 December 2020

Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

1 reference

12 December 2020

Mutant huntingtin enhances excitotoxic cell death.

1 reference

12 December 2020

Increase of total creatine in human brain after oral supplementation of creatine-monohydrate

1 reference

12 December 2020

Mechanism of transport and storage of neurotransmitters.

1 reference

12 December 2020

Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter

1 reference

12 December 2020

Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study

1 reference

12 December 2020

Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

1 reference

12 December 2020

Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

1 reference

12 December 2020

Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain

1 reference

12 December 2020

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

1 reference

12 December 2020

Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases

1 reference

12 December 2020

Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.

1 reference

12 December 2020

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

1 reference

12 December 2020

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

1 reference

12 December 2020

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.

1 reference

12 December 2020

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

1 reference

12 December 2020

Unified Huntington's disease rating scale: Reliability and consistency

1 reference

12 December 2020

Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts

1 reference

12 December 2020

Cerebral cation shifts and amino acids in Huntington's disease

1 reference

12 December 2020

Brain glutamate metabolism: neuronal-astroglial relationships

1 reference

12 December 2020

10.1007/S00415-005-0595-4

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1026138426

0 references

1 reference